First-In-Human Dose-Escalation Study of STP1002 in Patients with Advanced-Stage Solid Tumors
Details
Age
Adult
Type of Study
Treatment
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Christopher Lieu, MD
Study ID
Protocol Number: 19-3118
More information available at ClinicalTrials.gov: NCT04505839
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers